CASE REPORT
Neuromyelitis optica spectrum disorder – case report
1
Department of Rehabilitation, Regional Hospital, Kielce, Poland
2
Doctoral Studies, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
Submission date: 2015-07-23
Final revision date: 2016-02-15
Acceptance date: 2016-02-16
Publication date: 2016-04-05
Medical Studies 2016;32(1):45-48
KEYWORDS
TOPICS
ABSTRACT
The study presents the case of a 45-year-old woman with a rare case of Devic’s disease (neuromyelitis optica – NMO) admitted to the Department of Rehabilitation in Kielce. In her first interview she stated that for 2 years she had been experiencing an embracing pain in her torso, hemifacial pain and temporary deterioration in her lower limbs with sensory disorders of the body. Magnetic resonance imaging of the thoracic spine revealed a lesion of probably a demyelinating nature as well as a positive test for antibodies against aquaporin 4, for NMO identification. Due to relapse of the disease the patient was treated several times in the Department of Neurology, initially with plasmapheresis, methylprednisolone and then double immunosuppressive rituximab. At that time, the neurological condition of the patient was changing. The article presents the medical history, clinical course and treatment.
REFERENCES (10)
2.
Jurewicz A. Choroba Devica – nowe poglądy i nowe metody diagnostyczne. Pol Przegl Neurol 2010; 6 Suppl. A: 28-9.
3.
Rowland LP, Pedley TA. Neurology Merrit. Vol. 3. Kwieciński H, Kamińska AM (eds. Polish ed.). Elsevier U&P, Wrocław 2012.
4.
Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. J Neuroimmunol 2007; 187: 126-38.
5.
Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, Borisow N, Kleiter I, Aktas O, Kümpfel T; Update on diagnosis and treatment of neuromyelitis optica: Recommediations of Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014; 261: 82-9.
6.
Jordan B, Eger K, Kornhuber ME, Zierz S. Neuromyelitis optica: a separate disease entity associated with aquaporin-4 antibodies. Fortschr Neurol Psychiatr 2008; 76: 21-7.
7.
Zakrzewska-Pniewska B. Standardy diagnostyki i leczenia zapalenia nerwów wzrokowych i rdzenia Devica. Neurologia po Dyplomie 2011; 6: 14-21.
8.
Kimbrough DJ, Fujihara K, Jacob A, Lana-Peixoto MA, Leite MI, Levy M, Marignier R, Nakashima I, Palace J, de Seze J, Stuve O, Tenembaum SN, Traboulsee A, Waubant E, Weinshenker BG, Wingerchuk DM; GJCF-CC&BR.Treatment of neuromyelitis optica: review and recommendations. Mult Scler Relat Disorder 2012; 1: 180-7.
9.
Kurtzke J. Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS). J Neurol 1983; 33: 1444-52.
10.
Łuszczyńska A, Kuliński W. Physiotherapy in multiple sclerosis. Medical Studies 2015; 31: 168-77.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
